Bio-Rad Laboratories, Inc.
BIO
NYSE·Healthcare·Medical - Devices·Mkt cap $10.4B
$386.11
▼ -0.46%
P/E
46.58
Mkt Cap
$10.4B
52-Wk Range
$236.73–$396.23
52-Week Range
$236.73 - $396.23
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 33.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive product portfolio
- Global distribution network
- Advanced technological capabilities
- Strong research and development infrastructure
Bear Case
2 risks
- Average volatility.
- Premium valuation to Life Sciences Tools peers
Growth
Stable outlook
Increasing global research investments
Value
Premium valuation to Life Sciences Tools peers
Momentum
Hot
+32.5% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying BIO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 4, 2026
Reported EPS of $2.62 vs $1.75 consensus (+49.7% surprise). Revenue of $651.0M vs $624.0M expected (+4.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+49.7%
Revenue trend · last 8Q
—
-2%
-4%
+2%
+1%
+4%
+1%
-0%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$649.7M
$667.5M
$585.4M
$651.6M
$653.0M
$693.2M
$592.1M
$651.0M
Margins · last 8Q
Gross
53.1%
Operating
11.2%
Profit
57.0%
Wall Street consensus
3 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 5, 2026
vs Industry
How BIO stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related